Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOMBE: Nivolumab and Imiquimod in Vulvar Squamous Cell Carcinoma
NCT07679841Phase 2Not yet recruiting
- Sponsor
- Centre Léon Bérard
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, imiquimod in vulvar squamous cell carcinoma (VSCC), sponsored by Centre Léon Bérard. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nivolumabimiquimod
03
Conditions
vulvar squamous cell carcinoma (VSCC)
Beyond the preview
Go deeper on NCT07679841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07679841.